Serum cytokine concentrations in alcohol-dependent individuals without liver disease

Alcohol

Volumn 32, Issue 3, 2004, Pages 243-247

  Nicolaou, Chryssoula ^a   Chatzipanagiotou, Stylianos ^a   Tzivos, Dimitrios ^a   Tzavellas, Elias Odusseas ^a   Boufidou, Fotini ^a   Liappas, Ioannis Alexandros ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Alcohol; Cytokines; IL 6; Interleukin 6; Liver disease

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; MEASUREMENT; PHYSICAL EXAMINATION; RANDOMIZED CONTROLLED TRIAL; SAMPLE; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-6; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 3543095781     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2004.02.004     Document Type: Article

References (25)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.:1994;Author, Washington, DC
2. Bird G.L.A., Sheron N., Goka A.K.J., Alexander G.J., William R.S. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med. 112:1990;917-920
3. Bode C., Kugler V., Bode J.C. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol. 4:1987;8-14
4. Castilla A., Prieto J., Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med. 324:1991;933-940
5. Daniluk J., Szuster-Ciesielska A., Drabko J., Kandefer-Szerszen M. Serum cytokine levels in alcohol-related liver cirrhosis. Alcohol. 23:2001;29-34
6. Deviere J., Content J., Denys C., Vandenbussche P., Le Moine O., Schandene L., Vaerman J.P., Dupont E. Immunoglobulin A and interleukin-6 form a positive secretory feedback loop: a study of normal subjects and alcoholics cirrhotics. Gastroenterology. 103:1992;1296-1301
7. Deviere J., Content J., Denys C., Vandenbussche P., Schandene L., Wybran J., Dupont E. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin Exp Immunol. 77:1989;221-225
8. Felver M.E., Mezey E., McGuire M., Mitchell M.C., Herlong H.F., Veech G.A., Veech R.L. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res. 14:1990;255-259
9. Friedman H. Alcohol effects on cytokine responses by immunocytes. Alcohol Clin Exp Res. 22:(5 Suppl):1998;184S-187S
10. González-Quintela A., Dominguez-Santalla M.J., Pérez L.F., Vidal C., Lojo S., Barrio E. Influence of acute alcohol intake and alcohol withdrawal on circulating levels of IL-6, IL-8, IL-10 and IL-12. Cytokine. 12:2000;1437-1440
11. Hamilton M. The assessment of anxiety rates by rating. Br J Med Psychol. 32:1959;50-55
12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62
13. Hill D.B., Marsano L., Cohen D., Allen J., Shedlofsky S., McClain C.J. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med. 119:1992;547-552
14. Hill D.B., Marsano L.S., McClain C.J. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology. 18:1993;576-580
15. Huang Y.S., Chan C.Y., Wu J.C., Pai C.H., Chao Y., Lee S.D. Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol. 24:1996;377-384
16. Hughes P.H., Venulet J., Khant U., Medina Mora M.E., Navartnam V., Poshyachinda V., Rootman I., Salan R., Wadud K.A. Core Data for Epidemiological Studies on Nonmedical Drug Use. 1980;World Health Organization (WHO Offset Publication 56), Geneva. pp. 1-100
17. Joachim H. Klinbisch-chemischer Nachweis von chronischem Alkoholabusus. [The clinical chemical demonstration of chronic alcoholism.]. Dtsch Med Wochenschr. 120:1995;585
18. Khoruts A., Stahnke L., McClain C.J., Logan G., Allen J.I. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 in chronic alcoholic patients. Hepatology. 13:1991;267-276
19. Laso F.J., Iglesias M.C., Lopez A., Ciudad J., San Miguel J.F., Orfao A. Increased interleukin-12 serum levels in chronic alcoholism. J Hepatol. 28:1998;771-777
20. Le Moine O., Marchant A., De Groote D., Azar C., Goldman M., Deviere J. Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology. 22:1995;1436-1439
21. Magura S., Kang S.Y. Validity of self-reported drug use in high risk populations: a meta-analytical review. Subst Use Misuse. 31:1996;1131-1153
22. McClain C., Hill D., Schmidt J., Diehl A.M. Cytokines and alcoholic liver disease. Semin Liver Dis. 13:1993;170-182
23. Sheron N., Bird G., Goka J., Alexander G., Williams R. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp Immunol. 84:1991;449-453
24. Sun Z., Klein A.S., Radaeva S., Hong F., El-Assal O., Pan H.-n., Jaruga B., Batkai S., Hoshino S., Tian Z., Kunos G., Diehl A.M., Gao B. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology. 125:2003;202-215
25. World Health Organization. (1990). Composite International Diagnostic Interview. CIDI-Core Version 1.0, Division of Mental Health. Geneva: Author.